X-POSITION S stent

 

logo

The company Stentys S.A. was founded in 2006 for the development and production of coronary stents with the property of adaptive apposition - Self-Aporing ® Stent System
These stents are able to change the diameter after installation without the need for balloon post-dilatation, which facilitates the correct choice of the stent size for myocardial infarction and for certain anatomical characteristics of the affected area - the left coronary artery trunk, bifurcations, ectatic artery transformation, and other recalibration options.
The program of clinical trials, in which more than 2,500 patients participated, demonstrated excellent angiographic and long-term results of stenting, as well as high safety of stents with adaptive apposition by Stentys S.A.

Stents with adaptive apposition simplify the choice of stent size for myocardial infarction

xposition
Coronary stent with medication of X-position S for complex lesions.

Description:

Stentys SA, France - self-positioned ® nitinol stent intended for planned stenting of coronary arteries in the most difficult from an anatomical point of view situations - stenting of the left coronary artery trunk, bifurcation stenting, stenting of the coronary artery of conical shape , stenting with multiple lesions of the coronary arteries, other situations requiring special attention of the physician to the choice of the exact size of the stent.

Unlike all other known stents, the Xposition S coronary self-positioning stent coated with Sirolimus (manufacturer: Stentys SA, France) is capable of changing its diameter when the diameter of the arteries changes, such as when the arteries are narrowed against the background of excitement, or the arteries are widened against the background reception of vasodilator drugs. This unique stent construction, as well as the availability of an effective and safe drug coating with Sirolimus, provide the best early and long-term results of stenting, as evidenced by the results of major international studies. The use of a coronary stent with a medicamentous coating Xposition S (manufacturer: Stentys SA, France) guarantees no relapse of the disease and the maintenance of good blood flow in the stenting area.